Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., Youdim, M. B. H.·1990·Journal of Neural Transmission - Parkinson's Disease and Dementia Section

Cited by (445)

Items 301–400 of 445

  1. Does iron play a role in Parkinson's disease?
    Erika R. Bauminger, Maria Barcikowska, A. Friedman, Jolanta Gałązka-Friedman, Daniel Hechel, I. Nowik · 1994 · Hyperfine Interactions
  2. Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis
    Asunción Carmona, Eleonora Carboni, Lucas Caldi Gomes, Stéphane Roudeau, Fabian Maass, Christof Lenz, Richard Ortega, Paul Lingor · 2024 · Journal of Neurochemistry
  3. Native and Synthetic Ferritins for Nanobiomedical Applications: Recent Advances and New Perspectives
    Jose Manuel Dominguez-Vera, Belén Fernández, Natividad Gálvez · 2010 · Future Medicinal Chemistry
  4. Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells
    Ran Wang, Hong Qing, Xiaoqian Liu, Xiaolin Zheng, Yulin Deng · 2008 · Neuroscience Bulletin
  5. The Ferritin Superfamily
    Alejandro Yévenes · 2017 · Sub-cellular biochemistry/Subcellular biochemistry
  6. Calorie Restriction Down-Regulates Expression of the Iron Regulatory Hormone Hepcidin in Normal and d -Galactose–Induced Aging Mouse Brain
    Shougang Wei, Wenli Shi, Man Li, Qian Gao · 2013 · Rejuvenation Research
  7. Nutritional Iron Deprivation Attenuates Kainate‐Induced Neurotoxicity in Rats: Implications for Involvement of Iron in Neurodegeneration
    Shawn Shoham, Moussa B. H. Youdim · 2004 · Annals of the New York Academy of Sciences
  8. Targets, trials and tribulations in Alzheimer therapeutics
    Ruchita Gharat, Gargi Dixit, Mihir Khambete, Arati Prabhu · 2023 · European Journal of Pharmacology
  9. Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington’s disease patients
    Marjolein Bulk, Ingrid M. Hegeman-Kleinn, Boyd Kenkhuis, Ernst Suidgeest, Willeke van Roon‐Mom, Jan Lewerenz, Sjoerd G. van Duinen, Itamar Ronen, Louise van der Weerd · 2020 · NeuroImage Clinical
  10. Role of NADPH oxidase in cooperative reactive oxygen species generation in dopaminergic neurons induced by combined treatment with dieldrin and lindane
    Heera Sharma, Aaron C. Hirko, Michael A. King, Bin Liu · 2018 · Toxicology Letters
  11. The brain on fire?
    Gerald Cohen · 1994 · Annals of Neurology
  12. Iron deposition in subcortical nuclei of Parkinson’s disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies
    Jianing Jin, Dongning Su, Junjiao Zhang, Joyce S. T. Lam, Junhong Zhou, Tao Feng · 2024 · Chinese Medical Journal
  13. Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway?
    Stefano Gazzina, Enrico Premi, Isabella Zanella, Giorgio Biasiotto, Silvana Archetti, Maura Cosseddu, Elio Angelo Scarpini, Daniela Galimberti, María Serpente, Roberto Gasparotti et al. · 2015 · Neurodegenerative Diseases
  14. Graphene Quantum Dot Embedded Hydrogel for Dissolved Iron Sensing
    Daniel W. M. Pincher, Christie A. Bader, John D. Hayball, Sally E. Plush, Martin J. Sweetman · 2019 · ChemistrySelect
  15. Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging
    Dmitriy E. Korzhevsky, Olga V. Kirik, В. В. Гусельникова, Д. Л. Цыба, Elena A. Fedorova, I. P. Grigor’ev · 2021 · European Journal of Histochemistry
  16. Neuroinflammation and Alteration of the Blood-Brain Barrier in Alzheimer´s Disease
    Luis Oskar Soto-Rojas, Fidel de la Cruz‐López, Miguel Ángel Ontiveros‐Torres, Amparo Viramontes‐Pintos, María del Carmen Cárdenas‐Aguayo, Marco Antonio Meraz‐Ríos, Citlaltepetl Salinas‐Lara, Benjamí­n Florán, José Luna‐Muñoz · 2015 · InTech eBooks
  17. The Pathophysiological Basis of Parkinson’s Disease
    M. Gerlach, Peter Franz Riederer · 1993 · Milestones in drug therapy
  18. Nanoparticle-based colorimetric sensors to detect neurodegenerative disease biomarkers
    Qingqing Fan, Yuan Gao, Federico Mazur, Rona Chandrawati · 2021 · Biomaterials Science
  19. Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy
    Cristian Follmer · 2014 · Expert Review of Neurotherapeutics
  20. Serum Ceruloplasmin Depletion is Associated With Magnetic Resonance Evidence of Widespread Accumulation of Brain Iron in Parkinson's Disease
    Xiaojun Guan, Xueqin Bai, Cheng Zhou, Tao Guo, Jingjing Wu, Luyan Gu, Ting Gao, Xuchu Wang, Hongjiang Wei, Yuyao Zhang et al. · 2021 · Journal of Magnetic Resonance Imaging
  21. Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders
    Niels Bergsland, Eleonora Tavazzi, Ferdinand Schweser, Dejan Jakimovski, Jesper Hagemeier, Michael G. Dwyer, Robert Zivadinov · 2019 · CNS Drugs
  22. Concentration of calcium and magnesium and trace elements (zinc, copper, iron and manganese) in cerebrospinal fluid: A try of a pathophysiological classification
    Elena María González Romarís, Isabel Idoate, José Manuel González López, Jesús Fernando Escanero Marcén · 2010 · Journal of Trace Elements in Medicine and Biology
  23. Intranigral iron infusion in the rat
    Gregory J. Sengstock, Nasser H. Zawia, C. Warren Olanow, Adrian J. Dunn, Gary W. Arendash · 1997 · Biological Trace Element Research
  24. Exenatide-Modified Deferoxamine-Based Nanoparticles Ameliorates Neurological Deficits in Parkinson’s Disease Mice
    Yi‐Ming Huang, Xinran Wang, Wenjing Li, Feng Yue, Miao Wang, Feifan Zhou · 2024 · International Journal of Nanomedicine
  25. JWH133 inhibits MPP+-induced inflammatory response and iron influx in astrocytes
    Yi Jia, Han Deng, Qiuyu Qin, Zegang Ma · 2020 · Neuroscience Letters
  26. Iron as a trigger of neurodegeneration in Parkinson's disease
    Andrzej Friedman, Jolanta Gałązka-Friedman, Erika R. Bauminger · 2007 · Handbook of clinical neurology
  27. Caudate nucleus hypointensity in the elderly is associated with markers of neurodegeneration on MRI
    Adriaan C.G.M. van Es, Jeroen van der Grond, Anton J.M. de Craen, Faiza Behloul, Gerard J. Blauw, Mark A. van Buchem · 2007 · Neurobiology of Aging
  28. Fabrication and characterization of tosyl‐activated magnetic and nonmagnetic monodisperse microspheres for use in microfluic‐based ferritin immunoassay
    Frédéric Reymond, Christine Vollet, Zdeněk Plichta, Daniel Horák · 2013 · Biotechnology Progress
  29. Multi-compartment analysis of the complex gradient-echo signal quantifies myelin breakdown in premanifest Huntington's disease
    Chiara Casella, Elena Kleban, Anne Rosser, Elizabeth Jane Coulthard, Hugh Edward Rickards, Fabrizio Fasano, Claudia Metzler‐Baddeley, Derek Kenton Jones · 2021 · NeuroImage Clinical
  30. Dementia associated with haemochromatosis: a report of two cases
    Richard J. Harvey, John A. Summerfield, Nick C. Fox, Elizabeth K. Warrington, Martin N. Rossor · 1997 · European Journal of Neurology
  31. Increased iron content in the putamen of patients with striatonigral degeneration
    Shinsuke Kato, Shunsuke Meshitsuka, Eisaku Ohama, Junichi Tanaka, Josefina F. Llena, Atsushi Hirano · 1992 · Acta Neuropathologica
  32. A nuclear microscopic and histochemical study of iron concentrations and distribution in the midbrain of two age groups of monkeys unilaterally injected with MPTP
    Min-Qin Ren, Wei‐Yi Ong, Xinsheng Wang, F. Watt · 2003 · Experimental Neurology
  33. Differential Processing of the Ferritin Heavy Chain mRNA in Human Liver and Adult Human Brain
    Madhu S Dhar, J G Joshi · 1993 · Journal of Neurochemistry
  34. Dopamine‑iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease
    Chiara Buoso, Markus Seifert, Martin Lang, Corey M. Griffith, Begoña Talavera Andújar, Maria Paulina Castelo Rueda, Christine Fischer, Carolina Doerrier, Heribert Talasz, Alessandra Zanon et al. · 2024 · Neurobiology of Disease
  35. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review
    Michalina Józwiak, Marta Bauer, Wojciech Kamysz, Patrycja Kleczkowska · 2025 · Pharmaceuticals
  36. Estrés oxidativo y enfermedad de Alzheimer
    Félix Javier Jiménez Jiménez, Hortensia Alonso Navarro, Lucía Ayuso‐Peralta, Theresse Jabbour Wadih · 2006 · Revista de Neurología
  37. Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
    Leslie C. Jellen, Mechelle M. Lewis, Guangwei Du, Xi Wang, Martha L. Escobar Galvis, Stanisław Krzyżanowski, Colt D. Capan, Amanda M. Snyder, James R. Connor, Lan Kong et al. · 2021 · Scientific Reports
  38. Induction of RhoGAP and Pathological Changes Characteristic of Alzheimers Disease by UAHFEMF Discharge in Rat Brain
    Ing‐Feng Chang, Huo-Yen Hsiao · 2005 · Current Alzheimer Research
  39. Evaluation of ferritin and transferrin binding to tau protein
    Anna Jahshan, José O. Esteves-Villanueva, Sanela Martić · 2016 · Journal of Inorganic Biochemistry
  40. Cortical iron accumulation in MAPT ‐ and C9orf 72‐associated frontotemporal lobar degeneration
    Lucia A. A. Giannini, Marjolein Bulk, Boyd Kenkhuis, Ana Rajicic, Shamiram Melhem, Ingrid M. Hegeman-Kleinn, Lucia Bossoni, Ernst Suidgeest, Elise G.P. Dopper, John Cornelis Van Swieten et al. · 2023 · Brain Pathology
  41. Quantitative analysis of T2 signal intensities in Alzheimer's Disease
    Ramin V. Parsey, K.Rama Ranga Krishnan · 1998 · Psychiatry Research Neuroimaging
  42. Intranigral iron infusion in rats: A progressive model for excess nigral iron levels in Parkinson’s disease?
    Gary W. Arendash, C. Warren Olanow, Gregory J. Sengstock · 1993 · Key topics in brain research
  43. Oxidative Stress Indices in Parkinson's Disease: Biochemical Determination
    Moussa B. H. Youdim, Noam Driguès, Silvia A. Mandel · 2003 · Humana Press eBooks
  44. From niche methods to necessary tools: The growing importance of analytical atomic spectrometry in metal imaging in neuroscience
    E. McAllum, D. Hare · 2019 · Spectrochimica Acta Part B - Atomic Spectroscopy
  45. Iron in Parkinson disease, blood diseases, malaria and ferritin
    Erika R. Bauminger, I. Nowik · 1998 · Hyperfine Interactions
  46. Iron deposits in brain disorders
    K. A. Jellinger, E. Kienzl · 1993 · Key topics in brain research
  47. Fe2+ decreases the taurine-induced Cl− current in acutely dissociated rat hippocampal neurons
    Kuai Yu, Shaoyu Ge, Di‐Yun Ruan · 2003 · Brain Research
  48. Distribution of ferritin in the rat hippocampus after kainate-induced neuronal injury
    En Huang, Wei‐Yi Ong · 2004 · Experimental Brain Research
  49. Dendritic Translocation of the Rat Ferritin H Chain mRNA
    Tetsuya Ishimoto, Kazuhiro E. Fujimori, Michiki Kasai, Takahisa Taguchi · 2000 · Biochemical and Biophysical Research Communications
  50. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson’s disease and during ageing in non-Parkinsonian subjects
    Bodil Fornstedt · 2024 · Journal of Neural Transmission
  51. Norepinephrine–Fe(III)–ATP Ternary Complex and Its Relevance to Parkinson’s Disease
    Lu Kou, Yuemei Duan, Pengcheng Wang, Yaru Fu, Nerek Darabedian, Yonghui He, Dianlu Jiang, Dinglong Chen, Juan Xiang, Guokun Liu et al. · 2019 · ACS Chemical Neuroscience
  52. Iron level changes in the brain with neurodegenerative disease
    Robert Bazala, Giorgio Zoppellaro, G. Kletetschka · 2023 · Brain Multiphysics
  53. Role of Selenium, Iron, Copper, and Zinc in Parkinsonism
    G. Ali Qureshi, Shuja Ali Syed, S. Hasan Parvez · 2007 · Elsevier eBooks
  54. The Role of Metals in Alzheimer’s Disease
    Nabil Hajji, Carly Calvert, Craig William Ritchie, Magdalena Sastre · 2013 · Royal Society of Chemistry eBooks
  55. Inherited Disorders of Brain Iron Homeostasis
    Hyman M. Schipper, Prem Ponka · 2009 · Humana Press eBooks
  56. The Mechanisms of 6‐Hydroxydopamine‐Induced Astrocyte Death
    Nevena S. Zogovic, Aleksandra Mladenović, Milka Perović, Djordje M. Miljković, Vladimir Trajković · 2005 · Annals of the New York Academy of Sciences
  57. Synthesis of novel hydrophilic celastrol nanoformulation by entrapment within calcium phosphate nanoparticle and study of its antioxidant activity against neurotoxin-induced damage in human neuroblastoma cells
    Soumajit Chakrabarty, Susmita Nandi, Pathikrit Bandopadhyay, Abhijit Das, Md Azaharuddin, Anabadya Pal, Sourav Ghosh, Upasana Sett, Sanchita Nandy, Tarakdas Basu · 2024 · Biochemical and Biophysical Research Communications
  58. The Use of Biomarkers for Prediction and Prevention of Alzheimer’s and Parkinson’s Diseases
    Silvia A. Mandel, Amos D. Korczyn · 2012 · Advances in predictive, preventive and personalised medicine
  59. Apoptosis vs Nonapoptotic Mechanisms in Neurodegeneration
    K. A. Jellinger · 2003 · Humana Press eBooks
  60. Sensitive imaging of magnetic nanoparticles for cancer detection by active feedback MR
    Li Zhao, Chao‐Hsiung Hsu, Nikolay Dimitrov, Dennis W. Hwang, Hsin‐Wei Chang, Lian‐Pin Hwang, Yung‐Ya Lin · 2015 · Magnetic Resonance in Medicine
  61. Iron and Parkinson’s Disease
    Moussa B. H. Youdim, Dorit Ben‐Shachar, Peter Franz Riederer · 1994 · Birkhäuser Boston eBooks
  62. Localization of a new ferritin heavy chain sequence present in human brain mRNA to chromosome 11
    M. E. Percy, Sharon J. Bauer, Susan Rainey, Donald R. Crapper McLachlan, Madhu S Dhar, J G Joshi · 1995 · Genome
  63. Intranigral Iron Infusion as a Model for Parkinson’s Disease
    Gary W. Arendash, Gregory J. Sengstock, C. Warren Olanow, Stanley Barone, Adrian J. Dunn · 1994 · Springer eBooks
  64. Dopamine degrades ferritin by chaperone-mediated autophagy to elevate mitochondrial iron level in astroglial cells
    Som Dev, Somya Asthana, Pratibha Singh, Pankaj Seth, Chayanika Banerjee, Chinmay K. Mukhopadhyay · 2025 · Free Radical Biology and Medicine
  65. Biomedical applications of mammalian, bacterial, and archaeal ferritins – Targeted drug delivery and beyond
    Eliska Gruberova, Vladimír Pekařík, Kamil Musílek, Zbyněk Heger · 2025 · Nano Today
  66. Aggregation Induced Emission Supramolecular Functionalized Benzimidazole Hydrogel for Metal‐Ion Responsive and Fluorescent Anti‐Counterfeiting
    Yin‐Ping Hu, Muhammad Naeem, Jiao Wang, Hong Yao, You‐Ming Zhang, Tai‐Bao Wei, Qi Lin · 2022 · ChemistrySelect
  67. Effects of Fe2+ on ion channels: Na+ channel, delayed rectified and transient outward K+ channels
    Shaoyu Ge, D.-Y. Ruan, Kuai Yu, Jia-Hui Chen, M. Wang, Guisheng Zhong · 2001 · Food and Chemical Toxicology
  68. Estrogen enhances the inhibitory effect of iron on microglial nitric oxide production.
    Poonlarp Cheepsunthorn, Nootchanat Mairaue, Krongkan Nasee · 2006 · PubMed
  69. Inflammation, Free Radicals, Glycation, Metabolism and Apoptosis, and Heavy Metals
    Mark P. Mattson · 2001 · Elsevier eBooks
  70. Superoxide dismutase-like immunoreactivity in spheroids in Hallervorden-Spatz disease
    Kenichi Nishiyama, Shigeo Murayama, Y. Nishimura, Kei Asayama, Ichiro Kanazawa · 1997 · Acta Neuropathologica
  71. Green and Black Tea in Brain Protection
    Justyna Ostrowska, Wojciech Łuczaj, Agnieszka Augustyniak, Elźbieta Skrzydlewska · 2007 · Elsevier eBooks
  72. Effect of Water T2 Shortening in the Quantification of in‐vitro Proton MR Spectroscopy
    Juan Antonio Hernandez-Tamames, Virginia Mato‐Abad, Roberto García‐Álvarez, Javier Gonzalez, Javier Pereira Loureiro, Juan Álvarez‐Linera · 2015 · Journal of Neuroimaging
  73. Studies on the pathogenesis of Parkinson's disease in Japan
    Yoshikuni Mizuno, S Ikebe, Nobutaka Hattori, Hideki Mochizuki, Yuko Nakagawa-Hattori, T Kondo · 1994 · Archives of Gerontology and Geriatrics
  74. Use of Mri to Monitor Parkinson’s Disease
    Peggy J. Planetta, Janey Prodoehl, Daniel M. Corcos, David E. Vaillancourt · 2011 · Neurodegenerative Disease Management
  75. Contribution of Disturbed Iron Metabolism to the Pathogenesis of Parkinson‘s Disease
    Daniela Berg, Peter Franz Riederer, Manfred Gerlach · 2008 · Future Neurology
  76. Controversies about iron in parkinsonian and control substantia nigra
    Jolanta a zka- riedman · 2008
  77. Brain Iron and other Trace Metals in Neurodegenerative Diseases
    Manfred Gerlach, Moussa B. H. Youdim, Peter Franz Riederer · 2000 · Springer eBooks
  78. Letter to the editor
    Gilles Fénelon, G. Percheron, Joseph J. Jankovic, Manfred Gerlach, Kay L. Double, Peter Franz Riederer, Étienne C. Hirsch, K. A. Jellinger, Peter G. Jenner, Alfred Xaver TRAUTWEIN et al. · 1997 · Movement Disorders
  79. High resolution multi-parametric probabilistic in vivo atlas of dorsolateral nigral hyperintensity via 7 T MRI
    Marta Lancione, Graziella Donatelli, Gianmichele Migaleddu, Matteo Cencini, Paolo Bosco, Mauro Costagli, Roberto Ceravolo, Mirco Cosottini, Michela Tosetti, Laura Biagi · 2025 · Scientific Data
  80. The role of diffusion in ferritin-induced relaxation enhancement of protons
    Michael A. Boss, P. C. Hammel · 2012 · Journal of Magnetic Resonance
  81. pH induced reorganization of protein-protein interface in liposome encapsulated Ferritin at air/fluid and fluid/solid interfaces
    Maheshkumar Jaganathan, Chellappan Selvaraju, A. Dhathathreyan · 2020 · Journal of Molecular Liquids
  82. Role of cellular oxidative stress in dementia
    Giovanna Galliciotti, Antonella De Jaco, Diego Sepúlveda Falla, Emanuela D’Acunto, Elena Miranda · 2020 · Elsevier eBooks
  83. Diagnosis of Parkinson’s Disease—Transcranial Sonography in Relation to MRI
    L. Niehaus, Kai Boelmans · 2010 · International review of neurobiology
  84. Iron Deficiency and Excess in the Brain: Implications for Cognitive Impairment and Neurodegeneration
    Moussa B. H. Youdim, Manfred Gerlach, Peder Riederer · 2009 · Humana Press eBooks
  85. Parkinson's Disease: Mechanisms of Neuronal Death
    Evgenia E. Kolesnikova, Tatiana V. Serebrovskaya · 2003 · Neurophysiology
  86. The Application of Proteomics and Genomics to the Study of Age-Related Neurodegeneration and Neuroprotection
    Orly Weinreb, Noam Driguès, Yotam Sagi, Abraham Zeev Reznick, Tamar Amit, Moussa B. H. Youdim · 2006 · Antioxidants and Redox Signaling
  87. Cerebral oligemia and iron influence in cerebral structures — element of Morbus Parkinson Models?
    T. A. Sontag, Christine C. Heim, Wacław Kolasiewicz, J. Horn, Iancu Pardowitz, K.‐H. Sontag · 2006 · Springer eBooks
  88. Role of Copper and Other Transition Metal Ions in the Pathogenesis of Parkinson's Disease, Prion Diseases, Familial Amyotrophic Lateral Sclerosis, and Alzheimer's Disease
    Gerd Multhaup, Hermann H. Dieter, Konrad T. Beyreuther, Thomas A. Bayer · 2002 · Humana Press eBooks
  89. Role of Aluminum and Iron in Brain Disorders
    J G Joshi, Martin Clauberg, Madhu S Dhar · 1992 · Advances in behavioral biology
  90. Therapeutic Strategies and Metal-Induced Oxidative Stress: Application of Synchrotron Radiation Microbeam to Amyotrophic Lateral Sclerosis in the Kii Peninsula of Japan
    Sohei Yoshida · 2022 · Frontiers in Neurology
  91. Neurodegenerative Disease and Oxidative Stress: Insights from an Animal Model of Parkinsonism
    Teresa G. Hastings, Michael J. Zigmond · 1996 · Springer eBooks
  92. The regional distribution of T2-relaxation times in MR images of the substantia nigra and crus cerebri
    Constantin Mänz, Jana Godau, Daniela Berg, Benjamin Bender, Ulrike Ernemann, Uwe Klose · 2009 · Neuroradiology
  93. A new MRI ratio method for in-vivo estimation of signal hypointensity in aging and Alzheimer's disease
    Ramin V. Parsey, K. Ranga, Ranga Rama Krishnan · 1997 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  94. Calcifying Fibrous Tumor of the Jejunum in a 27-year-old Primigravid
    Marvin C. Masalunga, Jose M. Carnate · 2020 · Philippine Journal of Pathology
  95. Iron Chelation in Movement Disorders: Logical or Ironical
    Dinkar Kulshreshtha, Jacky Ganguly, Mandar Jog · 2021 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  96. Review of environmental chemicals and neurotoxicity : focus on neurological diseases.
    Susan Bull · 2007 · Europe PMC (PubMed Central)
  97. Sleep factors affecting mental health: mechanics and trigger factors
    Kathy Sexton–Radek · 2025 · Frontiers in Sleep
  98. Astroglial Iron Homeostasis and Neurodegenerative Diseases
    A.K. Mukherjee, Som Dev, Esha Ghosh, Somya Asthana, Chinmay K. Mukhopadhyay · 2022 · Springer eBooks
  99. Prediction and targeted prevention of Parkinson's and Alzheimer's diseases
    Silvia A. Mandel, Ilan J. Y. Halperin, Amos D. Korczyn, Micaela Morelli · 2009
  100. Multiscale X-Ray Analysis of Biological Cells and Tissues by Scanning Diffraction and Coherent Imaging
    Jan‐David Nicolas · 2019 · Göttingen series in x-ray physics